➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Boehringer Ingelheim
Colorcon
Johnson and Johnson
Mallinckrodt

Last Updated: September 25, 2021

DrugPatentWatch Database Preview

Actelion Company Profile


Email this page to a colleague

« Back to Dashboard

Summary for Actelion

Drugs and US Patents for Actelion

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actelion UPTRAVI selexipag TABLET;ORAL 207947-007 Dec 21, 2015 RX Yes No 9,173,881 ⤷  Try it Free ⤷  Try it Free
Actelion UPTRAVI selexipag TABLET;ORAL 207947-008 Dec 21, 2015 RX Yes No 10,828,298 ⤷  Try it Free Y ⤷  Try it Free
Actelion UPTRAVI selexipag TABLET;ORAL 207947-001 Dec 21, 2015 RX Yes No 10,821,108 ⤷  Try it Free Y ⤷  Try it Free
Actelion UPTRAVI selexipag TABLET;ORAL 207947-001 Dec 21, 2015 RX Yes No 8,791,122 ⤷  Try it Free Y Y ⤷  Try it Free
Actelion UPTRAVI selexipag TABLET;ORAL 207947-006 Dec 21, 2015 RX Yes No 9,173,881 ⤷  Try it Free ⤷  Try it Free
Actelion UPTRAVI selexipag TABLET;ORAL 207947-006 Dec 21, 2015 RX Yes No 7,205,302 ⤷  Try it Free Y Y ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Actelion

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Actelion ZAVESCA miglustat CAPSULE;ORAL 021348-001 Jul 31, 2003 5,472,969 ⤷  Try it Free
Actelion TRACLEER bosentan TABLET;ORAL 021290-002 Nov 20, 2001 5,292,740 ⤷  Try it Free
Actelion TRACLEER bosentan TABLET;ORAL 021290-001 Nov 20, 2001 5,292,740 ⤷  Try it Free
Actelion ZAVESCA miglustat CAPSULE;ORAL 021348-001 Jul 31, 2003 5,525,616 ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for ACTELION drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe for Oral Suspension 32 mg ➤ Subscribe 2019-02-08
➤ Subscribe Tablets 10 mg ➤ Subscribe 2017-10-18

Supplementary Protection Certificates for Actelion Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1345920 2014C/019 Belgium ⤷  Try it Free PRODUCT NAME: MACITENTAN ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; AUTHORISATION NUMBER AND DATE: EU/1/13/893 20131227
1400518 532 Finland ⤷  Try it Free
0526708 02C0042 France ⤷  Try it Free PRODUCT NAME: BOSENTAN MONOHYDRATE; NAT. REGISTRATION NO/DATE: EU/1/02/220/001 20020515; FIRST REGISTRATION: LI - 55841 20020228
1345920 14C0017 France ⤷  Try it Free PRODUCT NAME: MACITENTAN ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/13/893 20131220
2447254 325 10-2018 Slovakia ⤷  Try it Free PRODUCT NAME: SELEXIPAG; REGISTRATION NO/DATE: EU/1/15/1083 20160519
1400518 CR 2016 00048 Denmark ⤷  Try it Free PRODUCT NAME: SELEXIPAG ELLER ET SALT DERAF; REG. NO/DATE: EU/1/15/1083 20160519
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
McKesson
Merck
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.